Pantoprazole Novumgen (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Novumgen, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used in the treatment of acid‑related disorders in adults and adolescents. GNH USA supplies Pantoprazole Novumgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazole Novumgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Novumgen is a proton‑acid‑reduction ​     ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​

- Eros  ​    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​: Reduces gastric acid secretion to promote healing of erosive oesophageal lesions. - Gastro‑oesophageal reflux disease (GERD): Improves symptom control and healing of erosive esophagitis. - Peptic ulcer disease: Facilitates  ​          ​    ​    ​      ​     ​          ​ n  ​           t   t  t

");